John Crowley, president and CEO of the trade lobby group Biotechnology Innovation Organization, said in a statement that Pazdur's exit "raises serious concerns about the repeated turnover in key leadership" and risks U.S. biotech leadership as China seeks to compete in the sector...
No comments:
Post a Comment